Evidence map›Paper›PMID 39996884›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

The Healthcare Professionals' and Patient Advocates' Perspectives on the Care for Children with Cancer in Europe-A Report from the ESCALIER Project.

Maria Otth, Marko Ocokoljic, Theodora Armenkova, Irina Ban, Samira Essiaf, Maximilian Hopfgartner, Lejla Kameric, Pamela R Kearns, Georgia Kokkinou, Carmelo Rizzari and 2 more

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maria OtthDivision of Oncology-Hematology, Children's Hospital of Eastern Switzerland, 9006 St. Gallen, Switzerland.ORCID 0000-0002-2839-502X
Marko OcokoljicThe European Society for Paediatric Oncology (SIOP Europe), 1200 Brussels, Belgium.ORCID 0000-0003-1025-9166
Theodora ArmenkovaChildhood Cancer International-Europe (CCI Europe), 1080 Vienna, Austria.ORCID 0009-0005-1444-9276
Irina BanChildhood Cancer International-Europe (CCI Europe), 1080 Vienna, Austria.
Samira EssiafThe European Society for Paediatric Oncology (SIOP Europe), 1200 Brussels, Belgium.
Maximilian HopfgartnerChildhood Cancer International-Europe (CCI Europe), 1080 Vienna, Austria.
Lejla KamericChildhood Cancer International-Europe (CCI Europe), 1080 Vienna, Austria.
Pamela R KearnsThe European Society for Paediatric Oncology (SIOP Europe), 1200 Brussels, Belgium.ORCID 0000-0003-2756-5813
Georgia KokkinouChildhood Cancer International-Europe (CCI Europe), 1080 Vienna, Austria.
Carmelo RizzariThe European Society for Paediatric Oncology (SIOP Europe), 1200 Brussels, Belgium.ORCID 0000-0002-4828-3893
Carina SchneiderChildhood Cancer International-Europe (CCI Europe), 1080 Vienna, Austria.
Katrin ScheinemannDivision of Oncology-Hematology, Children's Hospital of Eastern Switzerland, 9006 St. Gallen, Switzerland.ORCID 0000-0002-3578-7152

Funding

Swiss Cancer Research Foundation HSR-5219-11-2020
6 · The paper itself

Abstract

Cancer in children and adolescents is rare. Therefore, experienced multidisciplinary teams of health care professionals and input from patient advocates are needed. Within the ESCALIER project, we present the current situation of care for children and adolescents with cancer in Europe from the perspective of these stakeholders and highlight the topics relevant for them. A survey developed by representatives from the European Society for Paediatric Oncology (SIOPE) and Childhood Cancer International-Europe (CCI-E) was sent to European paediatric oncologists and patient organizations. We analysed all six questions related to general aspects of care and ten questions especially relevant for SIOPE or CCI-E using descriptive statistics. In total, 159 paediatric oncologists from 35 European countries and 41 CCI-E member organizations from 30 countries replied. Six of the ten questions selected by SIOPE and CCI-E representatives were identical and covered topics from diagnosis to end of treatment and follow-up care. This highlights the alignment of topics relevant for both stakeholders. However, the answers provided by SIOPE and CCI-E respondents to the same questions differed to varying degrees, and answers also differed between respondents from the same country. The differences in the answers provided to our survey highlight the need to raise awareness, improve knowledge, and strengthen communication between different stakeholders, organisations, patients, and families. The stakeholders' different experiences and knowledge must be considered, and can thus strengthen common goals to provide the best possible care to children and adolescents with cancer in Europe.

Indexed as

Attitude of Health PersonnelHealth PersonnelNeoplasmsPatient AdvocacyAdolescentChildEuropeFemaleHumansMaleSurveys and QuestionnairescancerchildhoodEuropemalignancystandards of care

Identifiers

PMID39996884
PMCPMC11854544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.